CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC vs. Neurelis, Inc.

Explore the PTAB proceeding IPR2019-00451 filed by Aquestive Therapeutics, Inc. formerly Monosol RX, LLC on 2019-01-29. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2019-00451

Filing Date

2019-01-29

Accorded Filing Date

2019-01-29

Institution Decision Date

2019-08-13

Last Modified Date

2022-10-10

Proceeding Type

IPR

Termination Date

2020-08-06

Trial Status

Final Written Decision

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 14527613
Respondent Patent Number 9763876
Legal Expiration Date
2029-04-13 Active (2.4 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Steve Cartt et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

2 Total

Proceeding Status

Final Written Decision

Board Decisions & Rulings (2)

Termination 2020-08-06
Termination Decision Document
35 USC 312, 35 USC 318, 37 CFR 42.100
Denied (Patent Owner) 2019-09-27
Decision - Denying Patent Owner's Request on Rehearing of Decision on Institution - 37 CFR 42.71(d)
37 CFR 42.71

Address and Attorney/Agent Information

22 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name DLA Piper LLP (US)/Pittsburgh
Customer Number 185628
Address 1650 Market Street, Suite 5000, Philadelphia, PA, 19103, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
31750 Thomas Christenbury +1 215-656-3381
37878 Jill Mandelblatt +1 215-656-2482
38347 Lisa Haile +1 858-677-1456
42891 Raymond Miller +1 412-454-5000
42982 Michael Patane +1 609-505-8283
50229 Nancy Endejann +1 215-656-2490
54163 Joseph Helmsen +1 215-656-2480
54981 William Bartow +1 215-656-2458

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 10 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 3 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (10): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 3
USPTO PTAB Trial 2025-01-17
IPR2025-00464

Padagis US LLC et al. v. Neurelis, Inc.

U.S. Continuation Sibling (8895546)
Status: Terminated-Settled
USPTO PTAB Trial 2019-01-29
IPR2019-00450

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC v. Neurelis, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2019-01-28
IPR2019-00449

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC v. Neurelis, Inc.

Asserted Patent
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

200
45

Patent Owner Neurelis, Incs. Notice of Appeal Paper

2020-10-08 FILING PARTY: PATENT OWN
44

Termination Decision Document Paper

2020-08-06 FILING PARTY: BOARD
43

Hearing Transcript Paper

2020-05-27 FILING PARTY: BOARD
41

PETITIONER'S REPLY IN SUPPORT OF ITS MOTION TO EXCLUDE EVIDENCE Paper

2020-05-05 FILING PARTY: PETITIONER
42

Patent Owner's Reply to Petitionerยฟยฟยฟs Opposition to Patent Ownerยฟยฟยฟs Motion to Exclude Evidence Paper

2020-05-05 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc